Navigation Links
Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone

ng statement can be guaranteed. Among other risks, there can be no guarantee that the development of the products described in this release will be successful, that the products described in this release will receive regulatory approval, or that if approved, will be commercially successful. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Bristol- Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006, its Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.


In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. AstraZeneca has been named one of the "100 Best Companies for Working Mothers" by Working Mother magazine and is the only large pharmaceutical company named to FORTUNE magazine's 2007 list of "100 Best Companies to Work For." In 2006, for the
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
2. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
5. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
6. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
7. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
8. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
9. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

Post Your Comments:
(Date:11/6/2009)...N DIEGO, Nov. 6 Ardea Bi...company focused on the development of small-molecu...and human immunodeficiency virus (HIV), today repo...for the third quarter and nine months ended Septem...om/cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Since ...
(Date:11/6/2009)...SEARCH TRIANGLE PARK, N.C., Nov. 6 ...cing orally-available antiviral therapeutics to ad... on the development of the company,s lead antivira...on (WHO) and the Global Health Security Initiative...nt being developed for the treatment of smallpox, ...
(Date:11/6/2009)...LANTA, Nov. 6 GeoVax La..."the Company"), an Atlanta-based, biopharmaceutica...aused by HIV-1 (Human Immunodeficiency Virus) and ... quarter 2009 financial results and provided an op...sident and Chief Executive Officer commented, "We ...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 51576 1Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 51576 2Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 51576 3Drinking Wine Is Good For The 26quot 3BHeart 26quot 3B 26amp 3B Environment 51574 1Drinking Wine Is Good For The 26quot 3BHeart 26quot 3B 26amp 3B Environment 51574 2Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 1Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 2Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 3Reminder Program Dramatically Increases Mammography Rates Kaiser Permanente Study Finds 51572 4
...oday at 10:00 a.m. EDT -, TARRYTOWN, N.Y., Aug. 7...day announced its financial results for,the second...t pipeline is growing increasingly robust," said,M...cer of Emisphere,Technologies, Inc. "In addition t...nical development, we have an additional 11 pre-cl...
...linical and Preclinical Programs, NEW YORK, Aug. ...CA4), a developer of new drug treatments in the fi...is pleased to provide an,update covering its strat...d quarter of 2007. "Callisto has made substantial...ms in 2007," stated Gary S. Jacob, CEO of Callisto...
Other Medicine Technology:Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results 2Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results 3Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results 4Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results 5Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results 6Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results 7Callisto Reports on Second-Quarter 2007 Milestones 2Callisto Reports on Second-Quarter 2007 Milestones 3Callisto Reports on Second-Quarter 2007 Milestones 4
(Date:11/6/2009)...non of Georgia graduate was featured in a local ne...g abuse. The special report focused on the growing...he report Andrew shared his near death experience ... prescription drug abuse. ,, "I woke up, blinked o...my father on top of me giving me CPR. I saw tears ...
(Date:11/6/2009)...l loaded with pledge-breaking tax hikes ,, WASHI... Americans for Tax Reform: ,, By formally endors...arack Obama effectively announced that the central...g the campaign, Obama made a "firm pledge" not to ...ess than $250,000 per year: ,, "I can make a fir...
(Date:11/6/2009)...ation (NYSE: CNC ) today announced that it will p... the next few weeks. ,, Next week, at the Credit S...ld November 11-13, 2009, at the Arizona Biltmore R...nesday, November 11th at 4:30 p.m. Mountain Time. ...Centene,s presentation at: http://w.on24.com/r.h...
(Date:11/6/2009)...rtment of Veterans Affairs held a historic three-d...e beginning of a new mission for the agency - to e...n 1,300 VA clinicians and health care specialists,...roviding support for homeless and low-income veter...ers represented by the National Coalition for Home...
(Date:11/6/2009)...f Thousands of Idahoans Struggling with High Rx Co...s ,, BOISE, Idaho, Nov. 6 As the debate over ... House readies to vote on critical health care ref...ng on Idaho,s U.S. Representatives to support the ...America Act (H.R. 3962), which will close the Medi...
Breaking Medicine News(10 mins):Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2Health News:ATR: Obama Lied, His Tax Pledge Died 2Health News:ATR: Obama Lied, His Tax Pledge Died 3Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2Health News:VA Summit Frames Plan to End Veteran Homelessness 2Health News:AARP Calls On Idaho's U.S. Reps To Back House Health Care Reform Bill 2
...s a condition of the skin that affects more than 8...lts. While stress has often been cited // as a sou...d until now. Twenty-two university students par...ss for students. Stress levels were recorded using...
...search shows that pregnant women are at a higher r... legs syndrome is marked by // an urge to move the...umbness, tingling or burning sensations. Patients ...ptoms tend to progress with age. Researchers sa...
... and neglected children are much more likely to de...en who were not abused or neglected //, according ... self-destructive behaviors such as smoking, drug ...tional, physical or sexual abuse, physical neglect...
...er to help combat an increased risk for life-threa... and type II diabetes would be well // advised to ...ndard twice a day, according to a new study. Re...vascular disease. Results showed that blood sugar ...
...nt British study says that Man's best friend might...eptionally sensitive noses, // dogs can smell odor...dogs of varying breeds and ages were trained over ...rom six control group participants and one bladder...
...ing to a recent study researchers say the antidepr...nificantly reduce symptoms of fibromyalgia in wom...serotonin and // norepinephrine, two of the brain’...ss, headaches, sleep disturbances, and fatigue. Th...
Other Medicine News:
Millenova Immunology Laboratories
Marquette Clinical and Reference Laboratory
Quest Diagnostics
Mayo Medical Laboratories
Medicine Products: